Becton, Dickinson and Company (0R19.L)
USD 204.25
(1.41%)
USD 204.25
(1.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.11 Billion USD | -15.96% |
| 2022 | 2.51 Billion USD | -4.6% |
| 2021 | 2.63 Billion USD | 67.28% |
| 2020 | 1.57 Billion USD | -31.83% |
| 2019 | 2.3 Billion USD | 2.67% |
| 2018 | 2.24 Billion USD | 3.69% |
| 2017 | 2.16 Billion USD | 0.51% |
| 2016 | 2.15 Billion USD | 20.36% |
| 2015 | 1.79 Billion USD | 9.87% |
| 2014 | 1.63 Billion USD | 0.87% |
| 2013 | 1.61 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 513 Million USD | 5.56% |
| 2024 Q3 | 602 Million USD | -27.9% |
| 2024 Q2 | 835 Million USD | 62.77% |
| 2023 Q3 | 617 Million USD | -10.45% |
| 2023 Q2 | 689 Million USD | 9.37% |
| 2023 FY | 2.19 Billion USD | -12.58% |
| 2023 Q1 | 630 Million USD | 11.7% |
| 2023 Q4 | 486 Million USD | -21.23% |
| 2022 FY | 2.51 Billion USD | -4.6% |
| 2022 Q4 | 564 Million USD | -6.47% |
| 2022 Q3 | 603 Million USD | -17.4% |
| 2022 Q2 | 730 Million USD | -16.19% |
| 2022 Q1 | 871 Million USD | 49.4% |
| 2021 Q1 | 1.33 Billion USD | 32.44% |
| 2021 Q3 | 580 Million USD | 29.46% |
| 2021 FY | 2.63 Billion USD | 67.28% |
| 2021 Q4 | 583 Million USD | 0.52% |
| 2021 Q2 | 448 Million USD | -66.34% |
| 2020 Q3 | 435 Million USD | -36.68% |
| 2020 Q4 | 1 Billion USD | 131.03% |
| 2020 FY | 1.57 Billion USD | -31.83% |
| 2020 Q2 | 687 Million USD | 16.05% |
| 2020 Q1 | 592 Million USD | -33.71% |
| 2019 Q2 | 636 Million USD | -1.24% |
| 2019 FY | 2.3 Billion USD | 2.67% |
| 2019 Q4 | 893 Million USD | 19.39% |
| 2019 Q3 | 748 Million USD | 17.61% |
| 2019 Q1 | 644 Million USD | -15.26% |
| 2018 FY | 2.24 Billion USD | 3.69% |
| 2018 Q4 | 760 Million USD | 6.89% |
| 2018 Q3 | 711 Million USD | -0.28% |
| 2018 Q2 | 713 Million USD | 21.47% |
| 2018 Q1 | 587 Million USD | 4.63% |
| 2017 Q4 | 561 Million USD | -6.19% |
| 2017 FY | 2.16 Billion USD | 0.51% |
| 2017 Q1 | 561 Million USD | 11.53% |
| 2017 Q2 | 521 Million USD | -7.13% |
| 2017 Q3 | 598 Million USD | 14.78% |
| 2016 Q2 | 569 Million USD | 20.3% |
| 2016 Q3 | 612 Million USD | 7.56% |
| 2016 Q1 | 473 Million USD | -3.27% |
| 2016 Q4 | 503 Million USD | -17.81% |
| 2016 FY | 2.15 Billion USD | 20.36% |
| 2015 Q2 | 406 Million USD | 5.73% |
| 2015 Q1 | 384 Million USD | -7.91% |
| 2015 FY | 1.79 Billion USD | 9.87% |
| 2015 Q4 | 489 Million USD | -7.03% |
| 2015 Q3 | 526 Million USD | 29.56% |
| 2014 Q3 | 446 Million USD | 11.22% |
| 2014 Q2 | 401 Million USD | 6.08% |
| 2014 Q1 | 378 Million USD | -10.43% |
| 2014 FY | 1.63 Billion USD | 0.87% |
| 2014 Q4 | 417 Million USD | -6.5% |
| 2013 Q2 | 381 Million USD | -2.81% |
| 2013 Q1 | 392 Million USD | 0.0% |
| 2013 Q4 | 422 Million USD | -1.17% |
| 2013 FY | 1.61 Billion USD | 0.0% |
| 2013 Q3 | 427 Million USD | 12.07% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 1701.997% |
| Accuray Incorporated | 504 Thousand USD | -418749.206% |
| Align Technology, Inc. | 643.33 Million USD | -228.132% |
| Elevance Health Inc. | 133.96 Billion USD | 98.424% |
| AxoGen, Inc. | -21.46 Million USD | 9935.989% |
| Boston Scientific Corporation | 2.34 Billion USD | 9.902% |
| CVS Health Corporation | 13.74 Billion USD | 84.639% |
| Cardinal Health, Inc. | 1.24 Billion USD | -69.831% |
| Centene Corporation | 2.93 Billion USD | 27.952% |
| DaVita Inc. | 1.6 Billion USD | -31.708% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 78.072% |
| Hologic, Inc. | 970.2 Million USD | -117.584% |
| Humana Inc. | 4.01 Billion USD | 47.396% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -92.411% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -190.932% |
| Masimo Corporation | 136.5 Million USD | -1446.52% |
| McKesson Corporation | 3.9 Billion USD | 45.996% |
| Patterson Companies, Inc. | 252.92 Million USD | -734.638% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -67.274% |
| ResMed Inc. | 1.31 Billion USD | -59.937% |
| Henry Schein, Inc. | 615 Million USD | -243.252% |
| Teladoc Health, Inc. | -248.55 Million USD | 949.316% |
| Universal Health Services, Inc. | 1.17 Billion USD | -79.601% |
| Veeva Systems Inc. | 429.33 Million USD | -391.692% |
| Baxter International Inc. | 390 Million USD | -441.282% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -19.482% |
| Danaher Corporation | 5.38 Billion USD | 60.769% |
| Stryker Corporation | 3.88 Billion USD | 45.705% |
| Medtronic plc | 5.14 Billion USD | 58.962% |